Optellum, a medtech company that provides a ground-breaking AI platform to diagnose and treat early-stage lung cancer, is attending this year’s American Thoracic Society International Conference in conjunction with three prominent American healthcare institutions. Physicians from each of these institutions will demonstrate how integrating Optellum Virtual Nodule Clinic into their clinical workflows offers benefits for both patients and providers. Attendees at the conference can learn more about the application of the Optellum Virtual Nodule Clinic at these three scheduled...